Latest Regulatory News

Chilwa Minerals has finalised the last tranche of its $8 million private placement, bolstered by insider participation, and is advancing plans for a Nasdaq dual listing in the first half of 2026.

The Australian Competition and Consumer Commission has advanced its review of Ampol’s acquisition of EG Australia to a more detailed Phase 2 assessment, signalling potential competition concerns. Ampol remains optimistic about completing the deal by mid-2026 despite the regulatory scrutiny.

Terra Critical Minerals has amended its option agreement with ATHA Energy Corp to fast-track uranium exploration at the Pasfield Lake Project, increasing expenditure and drilling commitments in response to rising uranium prices.

The ACCC has referred Ampol’s acquisition of EG Australia to a detailed Phase 2 review, citing concerns that the deal could significantly reduce competition in key Australian fuel markets.

The ACCC has referred Ampol’s acquisition of EG Australia to a detailed Phase 2 review, citing significant competition concerns in multiple Australian fuel markets. Ampol’s proposed divestments have so far failed to satisfy the regulator.

Arrow Minerals maintains a cautious stance as regulatory ambiguity stalls its Guinea projects, while the country’s recent election brings a hopeful backdrop for resolution.

Galileo Mining Ltd has responded to an ASX price and volume query, confirming no undisclosed material information exists to explain recent trading activity. The company attributes the surge to positive market sentiment around its Norseman Project and lithium joint venture with Mineral Resources.

Coast Entertainment reports a robust first half of FY26 with significant growth in ticket sales and visitation, driven by new attractions and strong promotional campaigns. The Group also strengthens its financial position amid ongoing economic challenges.

Star Minerals has received mining approval for its Tumblegum South Gold Project and commenced grade control drilling, setting the stage for production in early 2026 amid rising gold prices.

Imricor Medical Systems has secured Virginia Commonwealth University Health as the third US site for its VISABL-AFL clinical trial, advancing its FDA approval pathway for MRI-guided cardiac ablation technology.

Paladin Energy reports a strong production ramp-up at its Langer Heinrich Mine and confirms robust progress on the Patterson Lake South project, supported by a strengthened balance sheet and a positive uranium market outlook.

Australian Strategic Materials and Energy Fuels are set to discuss their proposed acquisition in a joint webcast, offering investors a closer look at this strategic move.